Vision 2020: looking back and thinking forward on The Lancet Oncology Commissions

Mary K. Gospodarowicz; David A. Jaffray; Felicia M. Knaul

doi:10.1016/S1470-2045(20)30481-2

Vision 2020: looking back and thinking forward on The Lancet Oncology Commissions

Mary K. Gospodarowicz, David A. Jaffray, Felicia M. Knaul

Radiation Physics

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	1144-1146
Number of pages	3
Journal	The lancet oncology
Volume	21
Issue number	9
DOIs	https://doi.org/10.1016/S1470-2045(20)30481-2
State	Published - Sep 2020

ASJC Scopus subject areas

Oncology

Access to Document

10.1016/S1470-2045(20)30481-2

Cite this

@article{94ee3413652d4ea09450909a8601865b,

title = "Vision 2020: looking back and thinking forward on The Lancet Oncology Commissions",

author = "Gospodarowicz, {Mary K.} and Jaffray, {David A.} and Knaul, {Felicia M.}",

note = "Funding Information: DAJ reports patents from multiple licensees through University Health Network (Toronto, ON, Canada). FMK reports grants and personal fees from Merck KGaA and EMD Serono, and grants from Higia, Fundacion Axa, Pfizer, Roche, and Novartis, outside the submitted work. MKG declares no competing interests ",

year = "2020",

month = sep,

doi = "10.1016/S1470-2045(20)30481-2",

language = "English (US)",

volume = "21",

pages = "1144--1146",

journal = "The lancet oncology",

issn = "1470-2045",

publisher = "Lancet Publishing Group",

number = "9",

}

TY - JOUR

T1 - Vision 2020

T2 - looking back and thinking forward on The Lancet Oncology Commissions

AU - Gospodarowicz, Mary K.

AU - Jaffray, David A.

AU - Knaul, Felicia M.

N1 - Funding Information: DAJ reports patents from multiple licensees through University Health Network (Toronto, ON, Canada). FMK reports grants and personal fees from Merck KGaA and EMD Serono, and grants from Higia, Fundacion Axa, Pfizer, Roche, and Novartis, outside the submitted work. MKG declares no competing interests

PY - 2020/9

Y1 - 2020/9

UR - http://www.scopus.com/inward/record.url?scp=85090010847&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85090010847&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(20)30481-2

DO - 10.1016/S1470-2045(20)30481-2

M3 - Article

C2 - 32888451

AN - SCOPUS:85090010847

SN - 1470-2045

VL - 21

SP - 1144

EP - 1146

JO - The lancet oncology

JF - The lancet oncology

IS - 9

ER -

Vision 2020: looking back and thinking forward on The Lancet Oncology Commissions

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this